Reactivation and risk of sequelae in Langerhans cell histiocytosis

Pediatric Blood and Cancer

Volumn 48, Issue 7, 2007, Pages 696-699

  Podono, Daniel ^a   Rey, Guadalupe ^b   Latella, Antonio ^c   Rosso, Diego ^c   Chantada, Guillermo ^c   Braier, Jorge ^c  

^a Hospital de Ninos Sor Maria Ludovica   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Langerhans cell histiocytosis; Reactivation; Sequelae

Indexed keywords

ADOLESCENT; ARTICLE; BONE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HUMAN; HYPOTHALAMUS; INCIDENCE; INFANT; LANGERHANS CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SKIN; SYSTEMIC DISEASE; TREATMENT RESPONSE;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INCIDENCE; INFANT; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34248232472     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21145     Document Type: Article

References (20)

1. Arico M, Egeler M. Clinical aspects of Langerhans cell histiocytosis. In: Egeler RM, D'Angio GJ, editors. Hematology/oncology clinics of North America. Philadelphia: WB Saunders; 1998. pp 247-258.
2. Lahey E. Histiocytosis X: An analysis of prognostic factors. J Pediatr 1975;87:184-189.
3. Howarth DM, Gilchrist GS, Mullan BP, et al. Wiserman GA. Langerhans cell histiocytosis: Diagnosis, natural history, management, and outcome. Cancer 1999;85:2278-2290.
4. Haupt R, Nanduri V, Calevo MG, et al. Late effects and permanent consequences in Langerhans cell histiocytosis patients. A report from the LCH-late effects study group. Ped Blood Cancer 2004;42:438-444.
5. Jubran FR, Marachelian A, Dorey F. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 2005;45:37-42.
6. Thomas C, Donadieu J, Emile JF. Histiocitose Langerhansienne. Arch Pediatr 1996;3:63-69.
7. Willis B, Ablin A, Weinberg V, et al. Disease course and late sequelae of Langerhans cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996;14:2073-2082.
8. Nanduri VS, Pritchard J, Levitt G, et al. Long term morbidity and health-related quality of life after multi-system Langerhans cell histiocytosis. Eur J Cancer 2006;42:2563-2569.
9. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:72-80.
10. Ladisch S, Gadner H, Aricó M, et al. LCH I: A randomised trial of etoposide versus vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:107-110.
11. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. In: Egeler RM, D'Angio GJ, editors. Langerhans cell histiocytosis. Hematology oncology clinics of North America. Philadelphia: W.B. Saunders; 1998. pp 327-338.
12. Lucaya D. Histiocytosis X. Am J Dis Child 1971;121:289-295.
13. Grois N, Flucher-Wolfram B, Heitger A, et al. Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study. Med Pediatr Oncol 1995;24:248-256.
14. The French Langerhans Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17-24.
15. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans cell histiocytosis. J Pediatr 2001;138:728-734.
16. Kilpatrich SE, Wenger DE, Gilchrist GS, et al. Langerhans cell histiocytosis (histiocytosis X) of bone: A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 1995;76:24771-24784.
17. Braier J, Chantada G, Rosso D. Langerhans cell histiocytosis: Retrospective evaluation of 123 patients at a single institution. Ped Hematol Oncol 1999;16:377-385.
18. Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis: Data from the DAL-HX 83 and 90 study. Med Pediatr Oncol 2001;37:108-114.
19. Nanduri VR, Bareille P, Pritchard J, et al. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol 2000;53:509-515.
20. Donadieu J, Egeler RM, Pritchard J. Langerhans cell histiocytosis: A clinical update. In: Weitzman S, Egeler RM, editors. Histiocytic disorders of children and adults. Cambridge: Cambridge University Press; 2005. pp 95-129.